AELIX Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- AELIX Therapeutics's estimated annual revenue is currently $1.7M per year.
- AELIX Therapeutics's estimated revenue per employee is $155,000
Employee Data
- AELIX Therapeutics has 11 Employees.
- AELIX Therapeutics grew their employee count by -8% last year.
AELIX Therapeutics's People
| Name | Title | Email/Phone |
|---|
AELIX Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.4M | 41 | N/A | N/A | N/A |
#2 | $0.9M | 6 | N/A | N/A | N/A |
#3 | $5.9M | 38 | N/A | N/A | N/A |
#4 | $47M | 303 | 18% | N/A | N/A |
#5 | $9.5M | 61 | 11% | N/A | N/A |
#6 | $46.7M | 301 | 25% | N/A | N/A |
#7 | $1.7M | 11 | -8% | N/A | N/A |
#8 | $3.7M | 24 | -11% | N/A | N/A |
#9 | $4.2M | 27 | 13% | N/A | N/A |
#10 | $5.3M | 34 | 6% | N/A | N/A |
What Is AELIX Therapeutics?
AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Barcelona
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 11 | -15% | N/A |
#2 | $1.7M | 11 | -27% | N/A |
#3 | $1M | 11 | N/A | N/A |
#4 | $1M | 11 | -48% | N/A |
#5 | $1.4M | 11 | -27% | N/A |